
KARIM
BENABDELLAH EL KHLANJI
Publications (61) KARIM BENABDELLAH EL KHLANJI publications
2024
-
Application of Genomic Medicine in Africa: 14th Conference of the African Society of Human Genetics and the 2nd International Congress of the Moroccan Society of Genomics and Human Genetics, Rabat, Morocco 2022
American Journal of Tropical Medicine and Hygiene, Vol. 110, Núm. 6, pp. 1279-1284
-
Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy
Molecular Cancer, Vol. 23, Núm. 1
-
Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome
Frontiers in Immunology, Vol. 15
2023
-
CRISPR delivery with extracellular vesicles: Promises and challenges
Journal of Extracellular Biology, Vol. 2, Núm. 9
-
Estradiol and Estrone Have Different Biological Functions to Induce NF-κB-Driven Inflammation, EMT and Stemness in ER+ Cancer Cells
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-T treatment in B-ALL
Frontiers in immunology, Vol. 14, pp. 1165870
-
High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and Opportunities
Pharmaceuticals, Vol. 16, Núm. 6
-
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339
-
Preclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic Review
Stem Cells Translational Medicine, Vol. 12, Núm. 12, pp. 791-800
-
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi
Molecular Therapy Nucleic Acids, Vol. 34
-
The Black Hole: CAR T Cell Therapy in AML
Cancers, Vol. 15, Núm. 10
2022
-
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
Frontiers in Immunology, Vol. 13
-
Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells (Molecular Therapy - Oncolytics (2022) 25 (335–349), (S2372770522000687), (10.1016/j.omto.2022.05.003))
Molecular Therapy - Oncolytics
-
Genetic engineering of autologous or allogeneic immune effector cells
The EBMT/EHA CAR-T Cell Handbook (Springer International Publishing), pp. 7-10
-
Physiological lentiviral vectors for the generation of improved CAR-T cells
Molecular Therapy - Oncolytics, Vol. 25, pp. 335-349
-
Rnd3 Expression is Necessary to Maintain Mitochondrial Homeostasis but Dispensable for Autophagy
Frontiers in Cell and Developmental Biology, Vol. 10
2021
-
Baboon Envelope Pseudotyped “Nanoblades” Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells
Frontiers in Genome Editing, Vol. 3
-
Exosomes: Their role in pathogenesis, diagnosis and treatment of diseases
Cancers, Vol. 13, Núm. 1, pp. 1-45
-
Improved functionality of integration-deficient lentiviral vectors (IDLVs) by the inclusion of IS2 protein docks
Pharmaceutics, Vol. 13, Núm. 8